Advancing new approaches to restore lost human function

Recall Therapeutics is focused on developing therapies designed to restore the biological signals that support memory, strength, and aging.

Our work centers on diseases where people lose the fundamental functions that define independence and quality of life.

OUR MISSION

We’re on a mission to restore the functions disease and aging take away

Across Alzheimer’s disease, cancer-related cachexia, and age-related decline, patients experience a progressive loss of memory, strength, and resilience.

Recall Therapeutics was founded on the belief that advances in biology may enable new ways to restore these essential human functions. Our goal is to translate emerging scientific insights into therapies that could meaningfully improve patients’ lives.

Dan Salain

CEO & Co-Founder

THE CONNECTION

Connecting brain and body through biology

Many conditions that affect memory and physical health are treated independently.

Recall is exploring biological pathways that influence both cognitive function and systemic health — with the goal of restoring signals that support the brain and the body together.

This approach reflects a growing understanding that neurological and physical decline may be more connected than previously understood.

LEADERSHIP

Experienced leadership in biotechnology and translational science

Dan Salain

CEO & Co-Founder

Experienced biotechnology executive with a track record of building and scaling life sciences companies. Co-Founder & COO of Aceragen, where he helped raise $35M+ for rare-disease therapies; previously COO of Graybug Vision, contributing to $200M+ in financing including its $104M IPO.

Atul Chopra

Co-Founder & Chief Scientific Officer

Atul is a physician, medical geneticist, and biotechnology entrepreneur who discovered the hormone asprosin. He directs research at the Harrington Discovery Institute, treats patients with rare diseases, and founded Recall Therapeutics to translate biological breakthroughs into novel clinical treatments.

Brian Jackey

Chief Operating Officer

A pharmaceutical and biotechnology operations executive with over 25 years of leadership experience. They excel in directing massive manufacturing facilities, clinical development, contract manufacturing oversight, global technology transfers, process validation, supply chain strategies, and quality operations across diverse product modalities.

Max Salain

General Counsel & Secretary

Maxwell Salain is an innovative business and real estate attorney at Hahn Loeser. Combining a traditional legal foundation with creative strategic thinking, he leverages his entrepreneurial background to expertly guide his corporate clients through complex transactions, mergers, and financing matters.

Dan Salain

CEO & Co-Founder

Experienced biotechnology executive with a track record of building and scaling life sciences companies. Co-Founder & COO of Aceragen, where he helped raise $35M+ for rare-disease therapies; previously COO of Graybug Vision, contributing to $200M+ in financing including its $104M IPO.

Dan Salain

CEO & Co-Founder

Experienced biotechnology executive with a track record of building and scaling life sciences companies. Co-Founder & COO of Aceragen, where he helped raise $35M+ for rare-disease therapies; previously COO of Graybug Vision, contributing to $200M+ in financing including its $104M IPO.

Atul Chopra

Co-Founder & Chief Scientific Officer

Atul is a physician, medical geneticist, and biotechnology entrepreneur who discovered the hormone asprosin. He directs research at the Harrington Discovery Institute, treats patients with rare diseases, and founded Recall Therapeutics to translate biological breakthroughs into novel clinical treatments.

Brian Jackey

Chief Operating Officer

A pharmaceutical and biotechnology operations executive with over 25 years of leadership experience. They excel in directing massive manufacturing facilities, clinical development, contract manufacturing oversight, global technology transfers, process validation, supply chain strategies, and quality operations across diverse product modalities.

Max Salain

General Counsel & Secretary

Maxwell Salain is an innovative business and real estate attorney at Hahn Loeser. Combining a traditional legal foundation with creative strategic thinking, he leverages his entrepreneurial background to expertly guide his corporate clients through complex transactions, mergers, and financing matters.

SCIENTIFIC ADVISORS

Guided by leading Alzheimer’s researchers

Michael Rafii, MD, PhD

Scientific Advisor

Medical Director of the Alzheimer’s Therapeutic Research Institute at USC, widely recognized for advancing clinical research in Alzheimer’s disease. His expertise in clinical development and neurodegenerative research informs Recall’s scientific and clinical strategy.

Marwan Sabbagh, MD

Scientific Advisor

Neurologist and internationally recognized Alzheimer’s researcher affiliated with the Barrow Neurological Institute. His work on diagnosis, treatment, and clinical management of neurodegenerative disease informs the development of new therapeutic approaches.

OUR FOCUS

Targeting conditions where decline impacts daily life

Our work focuses on three areas where restoring lost function could have meaningful impact.

Alzheimer's Disease

Cancer-related Cachexia

Age-related Muscle Loss

These conditions affect millions of people and share underlying patterns of cognitive and systemic decline.

the platform

A fundamentally new way to reach the brain

Instead of targeting the brain directly, Recall is developing an approach that enables the body to produce signals that naturally reach it.

Most therapies for neurological diseases are limited by the challenge of accessing the brain. Recall’s approach is designed to work systemically — enabling therapeutic signals to circulate through the body and reach the brain through natural pathways. By activating biological mechanisms linked to memory and systemic health, this approach aims to restore function across both brain and body.

BEYOND MEMORY

We believe biology can restore essential human functions

Join our mailing list to receive updates on research progress and company developments.

BEYOND MEMORY

We believe biology can restore essential human functions

Join our mailing list to receive updates on research progress and company developments.

BEYOND MEMORY

We believe biology can restore essential human functions

Join our mailing list to receive updates on research progress and company developments.

BEYOND MEMORY

We believe biology can restore essential human functions

Join our mailing list to receive updates on research progress and company developments.

Restoring memory. Rebuilding the body. Restoring the biological signals that support memory, strength, and resilience.

STAY UPDATED

© 2026 Recall Therapeutics. All rights reserved.

Restoring memory. Rebuilding the body. Restoring the biological signals that support memory, strength, and resilience.

STAY UPDATED

© 2026 Recall Therapeutics. All rights reserved.

Restoring memory. Rebuilding the body. Restoring the biological signals that support memory, strength, and resilience.

STAY UPDATED

© 2026 Recall Therapeutics. All rights reserved.

Restoring memory. Rebuilding the body. Restoring the biological signals that support memory, strength, and resilience.

STAY UPDATED

© 2026 Recall Therapeutics. All rights reserved.